bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.758
+0.003 (0.37%)
At close: Jan 14, 2025, 4:00 PM
0.750
-0.007 (-0.99%)
After-hours: Jan 14, 2025, 7:42 PM EST
bioAffinity Technologies Employees
bioAffinity Technologies had 75 employees as of December 31, 2023. The number of employees increased by 61 or 435.71% compared to the previous year.
Employees
75
Change (1Y)
61
Growth (1Y)
435.71%
Revenue / Employee
$124,904
Profits / Employee
-$112,615
Market Cap
11.81M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 75 | 61 | 435.71% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
BIAF News
- 1 day ago - bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung - Business Wire
- 4 days ago - Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 4 weeks ago - Join bioAffinity Technologies' Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19 - Business Wire
- 4 weeks ago - bioAffinity Technologies Set for Continued Expansion in 2025 - Business Wire
- 2 months ago - bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 - Business Wire
- 2 months ago - bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development - Business Wire
- 2 months ago - bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung - Business Wire
- 3 months ago - WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement - PRNewsWire